Liquid biopsy in non-small cell lung cancer: Is it ready for prime time yet?

被引:1
|
作者
Shrestha, Prajwol [1 ,2 ]
Lee, Jenny [1 ,3 ]
Kao, Steven [1 ,4 ]
机构
[1] Chris OBrien Lifehouse, Camperdown, NSW, Australia
[2] Cent Coast Canc Ctr, Gosford, NSW, Australia
[3] Macquarie Univ, Sydney, NSW, Australia
[4] Univ Sydney, Sydney, NSW, Australia
关键词
EGFR; RECOMMENDATIONS; RESISTANCE;
D O I
10.1111/ajco.13788
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E3 / E4
页数:2
相关论文
共 50 条
  • [41] Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring
    Perez-Callejo, David
    Romero, Atocha
    Provencio, Mariano
    Torrente, Maria
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (05) : 455 - 465
  • [42] The Role of Serial Liquid Biopsy in the Management of Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Sama, Srikar
    Le, Thuy
    Ullah, Asad
    Elhelf, Islam A.
    Kavuri, Sravan K.
    Karim, Nagla Abdel
    CLINICS AND PRACTICE, 2022, 12 (03) : 419 - 424
  • [43] The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer
    Ezeife, Doreen A.
    Spackman, Eldon
    Juergens, Rosalyn A.
    Laskin, Janessa J.
    Agulnik, Jason S.
    Hao, Desiree
    Laurie, Scott A.
    Law, Jennifer H.
    Le, Lisa W.
    Kiedrowski, Lesli A.
    Melosky, Barbara
    Shepherd, Frances A.
    Cohen, Victor
    Wheatley-Price, Paul
    Vandermeer, Rachel
    Li, Janice J.
    Fernandes, Roxanne
    Shokoohi, Aria
    Lanman, Richard B.
    Leighl, Natasha B.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [44] Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
    Misako Nagasaka
    Mohammed Hafiz Uddin
    Mohammed Najeeb Al-Hallak
    Sarah Rahman
    Suresh Balasubramanian
    Ammar Sukari
    Asfar S. Azmi
    Molecular Cancer, 20
  • [45] The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer
    Ezeife, D.
    Spackman, E.
    Juergens, R.
    Laskin, J.
    Agulnik, J.
    Hao, D.
    Laurie, S.
    Law, J.
    Le, L.
    Kiedrowski, L.
    Melosky, B.
    Shepherd, F. A.
    Cohen, V.
    Wheatley-Price, P.
    Vandermeer, R.
    Li, J.
    Fernandes, R.
    Shokoohi, A.
    Lanman, R.
    Leighl, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S876 - S876
  • [46] Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
    Pi, Can
    Zhang, Ming-feng
    Peng, Xiao-xiao
    Zhang, Yi-chen
    Xu, Chong-rui
    Zhou, Qing
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (12) : 1089 - 1096
  • [47] Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
    Huang, Lanxiang
    Rong, Yuan
    Tang, Xuan
    Yi, Kezhen
    Wu, Jianyuan
    Wang, Fubing
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [48] Mutation analysis in liquid biopsy from Lithuanian non-small cell lung cancer patients
    Jarmalaite, S.
    Sestokaite, A.
    Gedvilaite, V.
    Sabaliauskaite, R.
    Cicenas, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 542 - 543
  • [49] The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
    Zhang, Yi-Chen
    Zhou, Qing
    Wu, Yi-Long
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [50] Circulating circTOLLIP serves as a diagnostic biomarker for liquid biopsy in non-small cell lung cancer
    Peng, Ziyi
    Hu, Qiuzhi
    Fang, Shuai
    Zhang, Xun
    Hong, Xin
    Tao, Lili
    Pan, Jinchang
    Jiang, Meina
    Bai, Huihui
    Wu, Yinuo
    Zhao, Xiaodong
    Zhou, Chengwei
    Chen, Jun
    Han, Ying
    Gong, Zhaohui
    CLINICA CHIMICA ACTA, 2021, 523 : 415 - 422